<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medalphabet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский алфавит</journal-title><trans-title-group xml:lang="en"><trans-title>Medical alphabet</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-5631</issn><issn pub-type="epub">2949-2807</issn><publisher><publisher-name>ООО «Альфмед»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33667/2078-5631-2022-27-67-72</article-id><article-id custom-type="elpub" pub-id-type="custom">medalphabet-2872</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КОСМЕТОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>КОСМЕТОЛОГИЯ</subject></subj-group></article-categories><title-group><article-title>Роль дерматокосметики в стратегии лечения пациентов с акне</article-title><trans-title-group xml:lang="en"><trans-title>Role of dermatocosmetics in treatment strategy for acne patients</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5044-5265</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Круглова</surname><given-names>Л. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kruglova</surname><given-names>L. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Круглова Лариса Сергеевна, д.м.н., проф., зав. кафедрой дерматовенерологии и косметологии</p><p> Москва </p></bio><bio xml:lang="en"><p>Kruglova Larisa S., DM Sci (habil.), professor, head of Dept of  Dermatovenereology and Cosmetology </p><p> Moscow </p></bio><email xlink:type="simple">kruglovals@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3437-5233</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Грязева</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Gryazeva</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Грязева Наталья Владимировна, к.м.н., доцент кафедры дерматовенерологии и косметологии</p><p> Москва </p></bio><bio xml:lang="en"><p>Gryazeva Natalya V., PhD Med, associate professor at Dept of Dermatovenereology and Cosmetology </p><p> Moscow </p></bio><email xlink:type="simple">tynrik@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1446-4450</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Вербовая</surname><given-names>Е. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Verbovaya</surname><given-names>E. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Вербовая Елена Дмитриевна, ординатор 2-го года кафедрыдерматовенерологии и косметологии</p><p> Москва </p></bio><bio xml:lang="en"><p>Verbovaya Elena D., 2-year intern of Dept of Dermatovenereology andCosmetology </p><p> Moscow </p></bio><email xlink:type="simple">verbovaya.lena@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ ДПО «Центральная государственная медицинская академия» Управления делами Президента Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Central State Medical Academy</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>30</day><month>11</month><year>2022</year></pub-date><volume>1</volume><issue>27</issue><issue-title>Дерматология (2)</issue-title><fpage>67</fpage><lpage>72</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Круглова Л.С., Грязева Н.В., Вербовая Е.Д., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Круглова Л.С., Грязева Н.В., Вербовая Е.Д.</copyright-holder><copyright-holder xml:lang="en">Kruglova L.S., Gryazeva N.V., Verbovaya E.D.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-alphabet.com/jour/article/view/2872">https://www.med-alphabet.com/jour/article/view/2872</self-uri><abstract><p>В соответствии с клиническими рекомендациями при акне любой тяжести рекомендовано бережное очищение и увлажнение с использованием средств специализированной дерматокосметики, восстанавливающих барьерные свойства кожи, обладающих противовоспалительным действием и не содержащих раздражающих кожу компонентов, а также комедогенных веществ. Бережный уход за кожей также должен сопровождать любую наружную и системную лекарственную терапию акне. В то же время безрецептурные препараты и средства по уходу за кожей, такие как некомедогенные очищающие и увлажняющие средства, успешно зарекомендовали себя в монотерапии легких форм акне и в качестве поддерживающей терапии. Гамма средств дерматокосметики Normaderm («Лаборатории Vichy») специально разработана с учетом потребностей склонной к жирности проблемной кожи при акне. В состав средств Normaderm входят различные активные вещества, позволяющие решать определенные проблемы при акне за счет воздействия на различные звенья патогенеза заболевания. В данной статье мы приводим клинические примеры применения специализированной косметики Vichy Normaderm у пациентов с акне в различных клинических ситуациях.</p></abstract><trans-abstract xml:lang="en"><p>In accordance with clinical recommendations for acne of any severity, gentle cleansing and moisturizing is recommended using specialized dermatocosmetics that restore the barrier properties of the skin, have an anti-inflammatory effect and do not contain skin-irritating components, as well as comedogenic substances. Gentle skin care should also accompany any topical and systemic acne drug therapy. At the same time, over-the-counter (OTC) skin care products, such as non-comedogenic cleansers and moisturizers, have been successful in both the monotherapy of mild acne and as maintenance therapy. The range of Normaderm dermatocosmetics (Vichy Laboratoires) is specially designed to meet the needs of oily acne prone skin. The composition of Normaderm products includes various active substances that allow solving certain problems with acne by influencing various links in the pathogenesis of the disease. In this article, we provide clinical examples of the use of specialized Vichy Normaderm cosmetics in patients with acne in various clinical situations.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>акне</kwd><kwd>нарушение барьерной функции кожи</kwd><kwd>дерматокосметика</kwd><kwd>Normaderm</kwd></kwd-group><kwd-group xml:lang="en"><kwd>acne</kwd><kwd>impaired skin barrier function</kwd><kwd>dermatocosmetics</kwd><kwd>Normaderm</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Tan JK, Bhate K. A global perspective on the epidemiology of acne. Br J Dermatol. 2015; 172 (Suppl 1): 3–12.</mixed-citation><mixed-citation xml:lang="en">Tan JK, Bhate K. A global perspective on the epidemiology of acne. Br J Dermatol. 2015; 172 (Suppl 1): 3–12.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Акне и розацеа. Под редакцией Кругловой Л.С. ГЭОТАР-Медиа. 2021. 207 с.</mixed-citation><mixed-citation xml:lang="en">Акне и розацеа. Под редакцией Кругловой Л.С. ГЭОТАР-Медиа. 2021. 207 с.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Rocha MA, Bagatin E. Adult-onset acne: Prevalence, impact, and management challenges. Clin Cosmet Investig Dermatol. 2018; 11: 59–69.</mixed-citation><mixed-citation xml:lang="en">Rocha MA, Bagatin E. Adult-onset acne: Prevalence, impact, and management challenges. Clin Cosmet Investig Dermatol. 2018; 11: 59–69.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Auffret N, Claudel JP, Leccia MT, Poli F, Farhi D, Dreno B. AFAST – adult female scoring tool: an easyto-use tool for scoring acne in adult females. J Eur Acad Dermatol Venerol. 2016; 30 (5): 824–828.</mixed-citation><mixed-citation xml:lang="en">Auffret N, Claudel JP, Leccia MT, Poli F, Farhi D, Dreno B. AFAST – adult female scoring tool: an easyto-use tool for scoring acne in adult females. J Eur Acad Dermatol Venerol. 2016; 30 (5): 824–828.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Bhargava S, Cunha PR, Lee J, Kroumpouzos G. Acne scarring management: systematic review and evaluation of the evidence. Am J Clin Dermatol. 2018; 19 (4): 459–477.</mixed-citation><mixed-citation xml:lang="en">Bhargava S, Cunha PR, Lee J, Kroumpouzos G. Acne scarring management: systematic review and evaluation of the evidence. Am J Clin Dermatol. 2018; 19 (4): 459–477.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Halvorsen JA, Stern RS, Dalgard F, Thoresen M, Bjertness E, Lien L. Suicidal ideation, mental health problems, and social impairment are increased in adolescents with acne: a population-based study. J Invest Dermatol. 2011; 131 (2): 363–370.</mixed-citation><mixed-citation xml:lang="en">Halvorsen JA, Stern RS, Dalgard F, Thoresen M, Bjertness E, Lien L. Suicidal ideation, mental health problems, and social impairment are increased in adolescents with acne: a population-based study. J Invest Dermatol. 2011; 131 (2): 363–370.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Dreno B, Pecastaings S, Corvec S, Veraldi S, Khammari A, Roques C. Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates. J Euro Acad Dermatol Venerol. 2018; 32 (Suppl 2): 5–14.</mixed-citation><mixed-citation xml:lang="en">Dreno B, Pecastaings S, Corvec S, Veraldi S, Khammari A, Roques C. Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates. J Euro Acad Dermatol Venerol. 2018; 32 (Suppl 2): 5–14.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Dreno B. What is new in the pathophysiology of acne, an overview. J Eur Acad Dermatol Venereol. 2017; 31 (Suppl 5): 8–12.</mixed-citation><mixed-citation xml:lang="en">Dreno B. What is new in the pathophysiology of acne, an overview. J Eur Acad Dermatol Venereol. 2017; 31 (Suppl 5): 8–12.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Dreno B, Shourick J, Kerob D, Bouloc A, Taieb C. The role of the exposome in acne: results from an international patient survey. J Eur Acad Dermatol Venereol. 2020; 34: 1057–1064.</mixed-citation><mixed-citation xml:lang="en">Dreno B, Shourick J, Kerob D, Bouloc A, Taieb C. The role of the exposome in acne: results from an international patient survey. J Eur Acad Dermatol Venereol. 2020; 34: 1057–1064.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Nast A, Dreno B, Bettoli V, et al. European evidence-based (S3) guideline for the treatment of acne – update 2016 – short version. J Eur Acad Dermatol Venereol. 2016; 30 (8): 1261–1268.</mixed-citation><mixed-citation xml:lang="en">Nast A, Dreno B, Bettoli V, et al. European evidence-based (S3) guideline for the treatment of acne – update 2016 – short version. J Eur Acad Dermatol Venereol. 2016; 30 (8): 1261–1268.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Fabbrocini G, Rossi AB, Thouvenin MD, et al. Fragility of epidermis: acne and post-procedure lesional skin. J Eur Acad Dermatol Venereol. 2017; 31 (Suppl 6): 3–18.</mixed-citation><mixed-citation xml:lang="en">Fabbrocini G, Rossi AB, Thouvenin MD, et al. Fragility of epidermis: acne and post-procedure lesional skin. J Eur Acad Dermatol Venereol. 2017; 31 (Suppl 6): 3–18.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Thiboutot D, Del Rosso JQ. Acne vulgaris and the epidermal barrier: Is acne vulgaris associated with inherent epidermal abnormalities that cause impairment of barrier functions? Do any topical acne therapies alter the structural and/or functional integrity of the epidermal barrier? J Clin Aesthet Dermatol. 2013; 6 (2): 18–24.</mixed-citation><mixed-citation xml:lang="en">Thiboutot D, Del Rosso JQ. Acne vulgaris and the epidermal barrier: Is acne vulgaris associated with inherent epidermal abnormalities that cause impairment of barrier functions? Do any topical acne therapies alter the structural and/or functional integrity of the epidermal barrier? J Clin Aesthet Dermatol. 2013; 6 (2): 18–24.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Gollnick HPM. From new findings in acne pathogenesis to new ap proaches in treatment. J Eur Acad Dermatol Venereol. 2015; 29 (Suppl. 5): 1–7.</mixed-citation><mixed-citation xml:lang="en">Gollnick HPM. From new findings in acne pathogenesis to new ap proaches in treatment. J Eur Acad Dermatol Venereol. 2015; 29 (Suppl. 5): 1–7.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Lynde CW, Andriessen A, Barankin B, et al. Moisturizers and ceramide-containing moisturizers may offer concomitant therapy with benefits. J Clin Aesthet Dermatol. 2014; 7 (3): 18–26.</mixed-citation><mixed-citation xml:lang="en">Lynde CW, Andriessen A, Barankin B, et al. Moisturizers and ceramide-containing moisturizers may offer concomitant therapy with benefits. J Clin Aesthet Dermatol. 2014; 7 (3): 18–26.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Lynde CW, Andriessen A, Barankin B, et al. Moisturizers and ceramide-containing moisturizers may offer concomitant therapy with benefits. J Clin Aesthet Dermatol. 2014; 7 (3): 18–26.</mixed-citation><mixed-citation xml:lang="en">Lynde CW, Andriessen A, Barankin B, et al. Moisturizers and ceramide-containing moisturizers may offer concomitant therapy with benefits. J Clin Aesthet Dermatol. 2014; 7 (3): 18–26.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Strauss JS, Krowchuk DP, Leyden JJ et al. Guidelines of care for acne vulgaris management. J Am Acad Dermatol 2007; 56: 651–663.</mixed-citation><mixed-citation xml:lang="en">Strauss JS, Krowchuk DP, Leyden JJ et al. Guidelines of care for acne vulgaris management. J Am Acad Dermatol 2007; 56: 651–663.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Shalita AR. Comparison of a salicylic acid cleanser and a benzoyl peroxide wash in the treatment of acne vulgaris. Clin Ther 1989; 11: 264–267.</mixed-citation><mixed-citation xml:lang="en">Shalita AR. Comparison of a salicylic acid cleanser and a benzoyl peroxide wash in the treatment of acne vulgaris. Clin Ther 1989; 11: 264–267.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Bowe WP, Shalita AR. Effective over-the-counter acne treatments. Semin Cutan Med Surg 2008; 27: 170–176.</mixed-citation><mixed-citation xml:lang="en">Bowe WP, Shalita AR. Effective over-the-counter acne treatments. Semin Cutan Med Surg 2008; 27: 170–176.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Bissonnette R, Bolduc C, Seite S et al. Randomized study comparing the efficacy and tolerance of a lipophilic hydroxy acid derivative of salicylic acid and 5% benzoyl peroxide in the treatment of facial acne vulgaris. J Cosmet Dermatol 2009; 8: 19–23.</mixed-citation><mixed-citation xml:lang="en">Bissonnette R, Bolduc C, Seite S et al. Randomized study comparing the efficacy and tolerance of a lipophilic hydroxy acid derivative of salicylic acid and 5% benzoyl peroxide in the treatment of facial acne vulgaris. J Cosmet Dermatol 2009; 8: 19–23.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Levesque A, Hamzavi I, Seite S et al. Randomized trial comparing a chemical peel containing a lipophilic hydroxy acid derivative of salicylic acid with a salicylic acid peel in subjects with comedonal acne. J Cosmet Dermatol 2011; 10: 174–178.</mixed-citation><mixed-citation xml:lang="en">Levesque A, Hamzavi I, Seite S et al. Randomized trial comparing a chemical peel containing a lipophilic hydroxy acid derivative of salicylic acid with a salicylic acid peel in subjects with comedonal acne. J Cosmet Dermatol 2011; 10: 174–178.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Yamaoka J, Kume T, Akaike A, Miyachi Y. Suppressive effect of zinc ion on iNOS expression induced by interferon-gamma or tumor necrosis factor-alpha in murine keratinocytes. J Dermatol Sci 2000; 23: 27–35.</mixed-citation><mixed-citation xml:lang="en">Yamaoka J, Kume T, Akaike A, Miyachi Y. Suppressive effect of zinc ion on iNOS expression induced by interferon-gamma or tumor necrosis factor-alpha in murine keratinocytes. J Dermatol Sci 2000; 23: 27–35.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Jarrousse V, Castex-Rizzi N, Khammari A et al. Zinc salts inhibit in vitro Toll-like receptor 2 surface expression by keratinocytes. Eur J Dermatol 2007; 17: 492–496.</mixed-citation><mixed-citation xml:lang="en">Jarrousse V, Castex-Rizzi N, Khammari A et al. Zinc salts inhibit in vitro Toll-like receptor 2 surface expression by keratinocytes. Eur J Dermatol 2007; 17: 492–496.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Isard O, Knol AC, Aries MF et al. Propionibacterium acnes activates the IGF-1/IGF-1R system in the epidermis and induces keratinocyte prolifera tion. J Invest Dermatol 2011; 131: 59–6.</mixed-citation><mixed-citation xml:lang="en">Isard O, Knol AC, Aries MF et al. Propionibacterium acnes activates the IGF-1/IGF-1R system in the epidermis and induces keratinocyte prolifera tion. J Invest Dermatol 2011; 131: 59–6.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Jeremy AHT, Holland DB, Roberts SG et al. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol 2003; 121: 20–27.</mixed-citation><mixed-citation xml:lang="en">Jeremy AHT, Holland DB, Roberts SG et al. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol 2003; 121: 20–27.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Dreno B, Castell A, Tsankov N et al. Interest of the association retinaldehyde/glycolic acid in adult acne. J Eur Acad Dermatol Venereol 2009; 23: 529–532,</mixed-citation><mixed-citation xml:lang="en">Dreno B, Castell A, Tsankov N et al. Interest of the association retinaldehyde/glycolic acid in adult acne. J Eur Acad Dermatol Venereol 2009; 23: 529–532,</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Elson ML. Differential effects of glycolic acid and tretinoin in acne vulgaris. Cosmet Dermatol 1992; 5: 36–40.</mixed-citation><mixed-citation xml:lang="en">Elson ML. Differential effects of glycolic acid and tretinoin in acne vulgaris. Cosmet Dermatol 1992; 5: 36–40.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Kar BR, Tripathy S, Panda M. Comparative study of oral isotretinoin versus oral isotretinoin + 20% salicylic Acid peel in the treatment of active acne. J Cutan Aesthetic Surg 2013; 6: 204–208.</mixed-citation><mixed-citation xml:lang="en">Kar BR, Tripathy S, Panda M. Comparative study of oral isotretinoin versus oral isotretinoin + 20% salicylic Acid peel in the treatment of active acne. J Cutan Aesthetic Surg 2013; 6: 204–208.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
